Therapeutic equivalence? [Design Issues]

posted by bjkim97  – Korea / Seoul, 2011-02-23 12:06 (5591 d 05:52 ago) – Posting: # 6663
Views: 8,795

Dear Dan

I understand your opinion. Anti-Cancer is not all cytotoxic. I agree with your opinion

You say about the imatinib that "No problem"
Then if so, did you think the tests are performed.

Please tell me studying about the imatinib of healthy volunteer.
Safety, AE (adverse event), specific issue eg.

Your advice is very helpful to me!

Kind regard
BJ

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
105 visitors (0 registered, 105 guests [including 21 identified bots]).
Forum time: 18:58 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5